nafamostat has been researched along with Blood Coagulation Disorders in 4 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Blood Coagulation Disorders: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms." | 2.72 | COVID-19-associated coagulopathy and disseminated intravascular coagulation. ( Asakura, H; Ogawa, H, 2021) |
| "The coagulo-fibrinolytic changes after acute pancreatitis was induced by the intraductal injection of an autologous bile and trypsin mixture showed decreased platelet counts, decreased plasma fibrinogen levels, prolonged partial prothrombin time and increased fibrinogen degradation products." | 1.28 | Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs. ( Ha, S; Haku, A; Hiura, A; Nishiwaki, H; Satake, K; Umeyama, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asakura, H | 1 |
| Ogawa, H | 1 |
| Odaka, M | 1 |
| Yamamoto, H | 1 |
| Kawaguchi, Y | 1 |
| Sakai, O | 1 |
| Satake, K | 1 |
| Ha, S | 1 |
| Hiura, A | 1 |
| Nishiwaki, H | 1 |
| Haku, A | 1 |
| Umeyama, K | 1 |
1 review available for nafamostat and Blood Coagulation Disorders
| Article | Year |
|---|---|
COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Topics: Adult; Anticoagulants; Benzamidines; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; | 2021 |
3 other studies available for nafamostat and Blood Coagulation Disorders
| Article | Year |
|---|---|
[Use of anticoagulant in continuous hemodiafiltration therapy].
Topics: Anticoagulants; Benzamidines; Blood Coagulation Disorders; Guanidines; Hemofiltration; Heparin; Huma | 1991 |
[Protease inhibitors as anticoagulant in hemodialysis].
Topics: Benzamidines; Blood Coagulation Disorders; Gabexate; Guanidines; Humans; Protease Inhibitors; Renal | 1991 |
Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs.
Topics: Acute Disease; Animals; Benzamidines; Blood Coagulation Disorders; Blood Coagulation Factors; Blood | 1990 |